Literature DB >> 31149251

THE ASSOCIATION OF PLASMA LEVELS OF miR-34a AND miR-149 WITH OBESITY AND INSULIN RESISTANCE IN OBESE CHILDREN AND ADOLESCENTS.

F Ahmadpour1, M Nourbakhsh1, M Razzaghy-Azar2,3, Sh Khaghani4, B Alipoor4, Z Abdolvahabi1, M Zangoei4.   

Abstract

CONTEXT: MicroRNAs (miRNAs) are short noncoding RNAs involved in posttranscriptional regulation of gene expression that influence various cellular functions including glucose and lipid metabolism and adipocyte differentiation.
OBJECTIVE: The aim of this study was to evaluate the levels of miR-34a and miR-149 and their relationship with metabolic parameters in obese children and adolescents.
DESIGN: Seventy children and adolescents were enrolled in the study. Plasma levels of microRNAs were evaluated by real-time PCR using SYBR green and analyzed by ΔCt method. Plasma concentrations of visfatin and insulin were measured by ELISA method. Glucose and lipid profile were determined colorimetrically. HOMA-IR was calculated and used as an index of insulin resistance (IR).
RESULTS: miR-34a was significantly lower in subjects with insulin resistance compared to obese children with normal insulin sensitivity. There was an inverse relationship between miR-34a levels and both insulin and HOMA-IR. On the other hand, miR-149 was significantly correlated with visfatin. There was no significant difference in miR-34a and miR-149 between obese and normal weight subjects.
CONCLUSIONS: miR-34a is associated with insulin and HOMA-IR and thus seems to be involved in IR. miR-149 is inversely associated with visfatin levels which could be indicative of anti-inflammatory effect of this miRNA.

Entities:  

Keywords:  insulin resistance; miR-149; miR-34a; obesity

Year:  2018        PMID: 31149251      PMCID: PMC6516521          DOI: 10.4183/aeb.2018.149

Source DB:  PubMed          Journal:  Acta Endocrinol (Buchar)        ISSN: 1841-0987            Impact factor:   0.877


  30 in total

1.  The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents.

Authors: 
Journal:  Pediatrics       Date:  2004-08       Impact factor: 7.124

2.  The metabolic syndrome in children and adolescents.

Authors:  Paul Zimmet; George Alberti; Francine Kaufman; Naoko Tajima; Martin Silink; Silva Arslanian; Gary Wong; Peter Bennett; Jonathan Shaw; Sonia Caprio
Journal:  Lancet       Date:  2007-06-23       Impact factor: 79.321

3.  The clinical biochemistry of obesity.

Authors:  Ken A Sikaris
Journal:  Clin Biochem Rev       Date:  2004-08

Review 4.  The regulation of nicotinamide adenine dinucleotide biosynthesis by Nampt/PBEF/visfatin in mammals.

Authors:  Javier R Revollo; Andrew A Grimm; Shin-ichiro Imai
Journal:  Curr Opin Gastroenterol       Date:  2007-03       Impact factor: 3.287

Review 5.  Recent advances in the relationship between obesity, inflammation, and insulin resistance.

Authors:  Jean-Philippe Bastard; Mustapha Maachi; Claire Lagathu; Min Ji Kim; Martine Caron; Hubert Vidal; Jacqueline Capeau; Bruno Feve
Journal:  Eur Cytokine Netw       Date:  2006-03       Impact factor: 2.737

6.  Homeostasis model assessment is more reliable than the fasting glucose/insulin ratio and quantitative insulin sensitivity check index for assessing insulin resistance among obese children and adolescents.

Authors:  Mehmet Keskin; Selim Kurtoglu; Mustafa Kendirci; M Emre Atabek; Cevat Yazici
Journal:  Pediatrics       Date:  2005-03-01       Impact factor: 7.124

7.  Growth curves for cardio-metabolic risk factors in children and adolescents.

Authors:  Stephen Cook; Peggy Auinger; Terry T-K Huang
Journal:  J Pediatr       Date:  2009-09       Impact factor: 4.406

8.  Nonalcoholic steatohepatitis is associated with altered hepatic MicroRNA expression.

Authors:  Onpan Cheung; Puneet Puri; Christoph Eicken; Melissa J Contos; Faridoddin Mirshahi; James W Maher; John M Kellum; Haeki Min; Velimir A Luketic; Arun J Sanyal
Journal:  Hepatology       Date:  2008-12       Impact factor: 17.425

9.  A microRNA component of the p53 tumour suppressor network.

Authors:  Lin He; Xingyue He; Lee P Lim; Elisa de Stanchina; Zhenyu Xuan; Yu Liang; Wen Xue; Lars Zender; Jill Magnus; Dana Ridzon; Aimee L Jackson; Peter S Linsley; Caifu Chen; Scott W Lowe; Michele A Cleary; Gregory J Hannon
Journal:  Nature       Date:  2007-06-06       Impact factor: 49.962

Review 10.  MicroRNAs: target recognition and regulatory functions.

Authors:  David P Bartel
Journal:  Cell       Date:  2009-01-23       Impact factor: 41.582

View more
  6 in total

Review 1.  MicroRNAs and obesity-induced endothelial dysfunction: key paradigms in molecular therapy.

Authors:  Karima Ait-Aissa; Quynh My Nguyen; Mohanad Gabani; Adam Kassan; Santosh Kumar; Soo-Kyoung Choi; Alexis A Gonzalez; Tahsin Khataei; Amal M Sahyoun; Cheng Chen; Modar Kassan
Journal:  Cardiovasc Diabetol       Date:  2020-09-09       Impact factor: 9.951

2.  Potential of Hibiscus sabdariffa Linn. in managing FGF21 resistance in diet-induced-obesity rats via miR-34a regulation.

Authors:  Neng Tine Kartinah; Nisa Komara; Nuraini Diah Noviati; Syarifah Dewi; Sophie Yolanda; Afifa Radhina; Heriyanto Heriyanto; Imelda Rosalyn Sianipar
Journal:  Vet Med Sci       Date:  2021-10-23

Review 3.  A Review of miRNAs as Biomarkers and Effect of Dietary Modulation in Obesity Associated Cognitive Decline and Neurodegenerative Disorders.

Authors:  Maddie Perdoncin; Alec Konrad; Joshua R Wyner; Samir Lohana; Sneha S Pillai; Duane G Pereira; Hari Vishal Lakhani; Komal Sodhi
Journal:  Front Mol Neurosci       Date:  2021-10-07       Impact factor: 6.261

4.  Association of miR-34a and miR-143 levels with PPARγ gene expression in adipose tissues of non-diabetic adults.

Authors:  Maryam Zarkesh; Kimia Tabaei; Mahdi Akbarzadeh; Afsoon Daneshafrooz; Azita Zadeh-Vakili
Journal:  J Physiol Anthropol       Date:  2022-04-09       Impact factor: 2.509

5.  EFFECT OF HYPEROSIDE ON THE INHIBITION OF ADIPOGENESIS IN 3T3-L1 ADIPOCYTES.

Authors:  M Berkoz
Journal:  Acta Endocrinol (Buchar)       Date:  2019 Apr-Jun       Impact factor: 0.877

6.  Predicting Nonalcoholic Fatty Liver Disease through a Panel of Plasma Biomarkers and MicroRNAs in Female West Virginia Population.

Authors:  Sneha S Pillai; Hari Vishal Lakhani; Mishghan Zehra; Jiayan Wang; Anum Dilip; Nitin Puri; Kathleen O'Hanlon; Komal Sodhi
Journal:  Int J Mol Sci       Date:  2020-09-13       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.